Stratec SE (ETR:SBS – Get Free Report)’s share price was up 1.8% during trading on Tuesday . The stock traded as high as €20.20 and last traded at €20.05. 6,241 shares were traded during mid-day trading, a decline of 0% from the average session volume of 6,253 shares. The stock had previously closed at €19.70.
Stratec Price Performance
The company has a market capitalization of $246.28 million, a price-to-earnings ratio of 24.60, a PEG ratio of 10.43 and a beta of 0.80. The company’s 50 day simple moving average is €18.09 and its 200-day simple moving average is €19.12. The company has a current ratio of 4.33, a quick ratio of 1.65 and a debt-to-equity ratio of 49.40.
About Stratec
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
Further Reading
- Five stocks we like better than Stratec
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.
